PTEN regulates Mdm2 expression through the P1 promoter

Chun-Ju Chang1, Daniel J Freeman, Hong Wu

  • 1Department of Molecular and Medical Pharmacology and Howard Hughes Medical Institute, University of California School of Medicine, Los Angeles, California 90095-1735, USA.

Insights

Phosphatase and tensin homolog (PTEN) regulates the MDM2 oncoprotein by controlling its transcription and isoform selection via the P1 promoter. This discovery reveals a new mechanism for PTEN in managing MDM2 functions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MDM2 is an oncoprotein crucial for tumorigenesis, regulated by p53 and AKT signaling.
  • PTEN antagonizes AKT signaling, previously shown to inhibit MDM2 nuclear translocation and protein stability.
  • The precise mechanisms by which PTEN influences MDM2, particularly its transcriptional regulation and isoform expression, require further elucidation.

Purpose of the Study:

  • To investigate the novel role of PTEN in regulating MDM2 transcription and isoform selection.
  • To determine the impact of PTEN on MDM2 P1 promoter activity.
  • To elucidate the mechanism by which PTEN controls MDM2 P1 promoter activity, including its dependence on p53 and lipid phosphatase activity.

Main Methods:

  • Analysis of Mdm2 P1 promoter activity in Pten-null and wild-type cell lines.
  • Assessment of L-Mdm2 expression and p90(MDM2) isoform production.
  • Investigation of PTEN's lipid phosphatase activity in regulating Mdm2 P1 promoter activity.
  • Evaluation of the p53-independent nature of PTEN's regulation of Mdm2 P1 promoter.

Main Results:

  • PTEN negatively regulates Mdm2 P1 promoter activity.
  • Pten-null cell lines and prostate cancer tissues exhibit up-regulated Mdm2 P1 promoter activity.
  • This up-regulation leads to increased L-Mdm2 expression and enhanced p90(MDM2) isoform production.
  • PTEN controls Mdm2 P1 promoter activity via its lipid phosphatase activity, independent of p53.

Conclusions:

  • PTEN plays a novel role in modulating Mdm2 transcription and isoform selection by negatively regulating the Mdm2 P1 promoter.
  • Loss of PTEN function results in increased Mdm2 P1 promoter activity, leading to higher levels of L-Mdm2 and p90(MDM2) isoforms.
  • PTEN's regulation of Mdm2 P1 promoter activity is independent of p53 and relies on its lipid phosphatase function, offering a new perspective on PTEN's tumor-suppressive mechanisms.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...